Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary Syndrome
Latest Information Update: 31 Mar 2022
At a glance
- Drugs Ezetimibe (Primary) ; Pitavastatin (Primary)
- Indications Acute coronary syndromes; Cardiovascular disorders; Dyslipidaemias; Unstable angina pectoris
- Focus Therapeutic Use
- Acronyms HIJ-PROPER
- 01 Feb 2022 Results (n=226)of sub analysis investigating the association between the left atrial volume index (LAVI) and the incidence of cardiovascular events in patients with acute coronary syndrome (ACS) who did not have atrial fibrillation, published in the Echocardiography
- 03 Apr 2021 Results (N=965) of post hoc subanalysis assessing relationship between changes in the EPA/AA ratio under lipid-lowering therapy other than PUFAs and cardiovascular events, published in the Circulation Journal
- 01 Nov 2020 Results of sub analysis assessing the effects of lipid lowering therapy on Serum Eicosapentaenoic Acid to Arachidonic Acid ratio, published in the Journal of Cardiovascular Pharmacology and Therapeutics